The Laboratory automation market share in 2026 covers pre-analytical, analytical, and post-analytical processes, allowing laboratories to manage increasing sample volumes and complex testing requirements efficiently. The growing focus on precision, compliance, operational efficiency, and quality control is supporting the adoption of automated workflows. Automation is also expanding across diagnostics, genomics, personalized medicine, drug discovery, and research applications.
According to Fortune Business Insights, the global laboratory automation market size was valued at USD 9.2 billion in 2025. The market is projected to grow from USD 10.07 billion in 2026 to USD 20.71 billion by 2034, exhibiting a CAGR of 9.43% during the forecast period. Laboratory automation includes technologies and systems designed to streamline, standardize, and optimize laboratory workflows through automated instruments, robotics, software, and integrated platforms. These solutions help reduce manual intervention, improve accuracy, enhance reproducibility, and increase throughput across clinical diagnostics, pharmaceutical research, biotechnology, and academic laboratories.
𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀 & 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀:
The rising demand for high-throughput, accurate, and reproducible laboratory operations is a major factor supporting laboratory automation market growth. Pharmaceutical, biotechnology, and clinical laboratories are experiencing increasing sample volumes and workflow complexity, making manual processing inefficient and more susceptible to errors. Automated systems enable consistent protocol execution, reduce human error, and accelerate turnaround times. In drug discovery, automated screening platforms allow rapid testing of large numbers of compounds, while clinical laboratories benefit from automated specimen handling and analysis. Workforce shortages further increase the need for automated laboratory operations.
However, high initial capital investment remains a significant restraint. Automated laboratory systems can require substantial expenditure on equipment, software, infrastructure upgrades, and employee training. Smaller laboratories and academic institutions may experience budget limitations that delay adoption. Integration with legacy instruments and laboratory information systems can also be complex and time-consuming. Workflow redesign and validation requirements may further slow implementation.
The expansion of automation in diagnostics and personalized medicine represents a major opportunity. Advanced diagnostic testing, genomics, and molecular assays require precise and standardized workflows that are well suited to automation. At the same time, workforce adaptation and change management remain challenges because laboratory personnel require training to operate, maintain, and interpret automated systems. Data integrity and cybersecurity also add complexity to automated laboratory environments.
𝗠𝗮𝗿𝗸𝗲𝘁 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲:
The competitive landscape includes leading companies developing devices, software, robotics, automated liquid handling systems, laboratory platforms, and related solutions. The companies identified by Fortune Business Insights include QIAGEN, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher Corporation, Agilent Technologies, Inc., Eppendorf SE, Hudson Lab Automation, F. Hoffmann-La Roche Ltd, Hamilton Company, and BMG LABTECH GmbH. Thermo Fisher Scientific Inc. accounted for 16% of the market share, while Danaher Corporation accounted for 14%.
𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀:
By Product (Devices, Software, and Accessories)
By Type (Plate Readers, Automated Liquid Handling Systems, Robotic Systems, Storage Retrieval Systems, Dissolution Testing Systems, Sample Transport Systems, Specimen Handling Systems, and Others)
By Automation Type (Total Automation Systems and Modular Automation Systems)
By Application (Drug Discovery & Development, Diagnostics, and Others)
By End-User(Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others)
Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/laboratory-automation-market-111623
𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀:
North America held approximately 37% of the global laboratory automation market, making it the leading region. The region benefits from a developed pharmaceutical and biotechnology ecosystem, large clinical and diagnostic laboratory networks, strong research funding, and early adoption of advanced technologies. Europe accounted for nearly 28% of the market, supported by academic research, pharmaceutical manufacturing, regulatory harmonization, quality assurance, and standardized workflows.
Asia-Pacific commanded approximately 25% of the market and is experiencing expanding healthcare infrastructure, pharmaceutical manufacturing, research capacity, diagnostics, and laboratory modernization. The Rest of the World accounted for approximately 10% and is witnessing gradual adoption supported by healthcare modernization and increasing laboratory capacity.
Germany represented approximately 10% of Europe’s market, while the U.K. accounted for around 8% of Europe’s market. Japan represented about 7% of the Asia-Pacific market, and China accounted for nearly 11% of the Asia-Pacific market.
𝗙𝘂𝘁𝘂𝗿𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗰𝗼𝗽𝗲:
The future of the laboratory automation market is expected to be shaped by intelligent automation, modular architecture, digital integration, robotics, automated liquid handling, and AI-enabled laboratory software. Investment is increasingly focused on technologies that reduce manual intervention, improve reproducibility, support scalability, and strengthen data integrity. Diagnostics automation, genomics workflows, molecular testing, decentralized laboratories, and satellite laboratories represent important opportunity areas.
New product development is emphasizing AI-powered workflow orchestration, predictive maintenance, self-optimizing robotic platforms, compact automation systems, cloud-enabled solutions, and interoperability with laboratory information systems. Modular platforms are allowing laboratories to scale automation according to workload requirements, while user-centric designs can support easier adoption and training. As laboratory infrastructure continues to modernize, automation is positioned to support higher throughput, standardized workflows, traceability, and operational efficiency across research, diagnostics, pharmaceutical, and biotechnology environments.
Explore Japan’s Market Opportunities - Latest -Laboratory Automation Market- Insights